Search Clinical Trials
598,375 trials
ID
Status
Phase
Title
Sponsor
NCT07766642
A Clinical Trial to Evaluate the Effects of a Supplement on Children's Focus and EnergyAuri NutritionActive Not RecruitingNot Applicable
NCT07766642Active Not Recruiting
Not Applicable
A Clinical Trial to Evaluate the Effects of a Supplement on Children's Focus and...Auri Nutrition
NCT07765316
Targeting Pathogenic Myelopoiesis in Pancreatic CancerIRCCS San RaffaeleNot Yet Recruiting
NCT07765316Not Yet Recruiting
—
Targeting Pathogenic Myelopoiesis in Pancreatic CancerIRCCS San Raffaele
NCT07765121
ViaMente: Feasibility of a Nurse-Led Group Programme for Burnout and Well-Being in Mental Healthcare ProfessionalsCentro Hospitalar Lisboa OcidentalCompletedNot Applicable
NCT07765121Completed
Not Applicable
ViaMente: Feasibility of a Nurse-Led Group Programme for Burnout and Well-Being...Centro Hospitalar Lisboa...
NCT07766603
Preoperative Breathing Exercise Training and Postoperative Delirium After Robotic Radical ProstatectomyALİ DEMİRTAŞNot Yet RecruitingNot Applicable
NCT07766603Not Yet Recruiting
Not Applicable
Preoperative Breathing Exercise Training and Postoperative Delirium After Roboti...ALİ DEMİRTAŞ
NCT07765797
Development and Validation of a Scale of Propensity for Change in Chronic Disease PreventionUniversity Hospital, ToulouseNot Yet Recruiting
NCT07765797Not Yet Recruiting
—
Development and Validation of a Scale of Propensity for Change in Chronic Diseas...University Hospital, Toul...
NCT07766772
Trastuzumab Rezetecan Followed by Pyrotinib, and Trastuzumab Combined With Capecitabine as First-line Treatment for Advanced HER2-positive Breast CancerFujian Cancer HospitalNot Yet RecruitingPhase 2
NCT07766772Not Yet Recruiting
Phase 2
Trastuzumab Rezetecan Followed by Pyrotinib, and Trastuzumab Combined With Capec...Fujian Cancer Hospital
NCT07765433
Testing the Addition of Ivonescimab Combined With Standard Chemotherapy Compared to the Usual Chemotherapy and Immunotherapy Treatment for Patients With Advanced Biliary Tract CancerECOG-ACRIN Cancer Research GroupNot Yet RecruitingPhase 2
NCT07765433Not Yet Recruiting
Phase 2
Testing the Addition of Ivonescimab Combined With Standard Chemotherapy Compared...ECOG-ACRIN Cancer Researc...
NCT07765537
A Phase I/II Open-label, Single-arm, Multicenter Clinical Study to Evaluate the Safety and Efficacy of FKC289 in Subjects With Relapsed/Refractory Membranous NephropathyShenzhen Fosun Kairos Biotechnology Co., Ltd.Not Yet RecruitingPhase 1
NCT07765537Not Yet Recruiting
Phase 1
A Phase I/II Open-label, Single-arm, Multicenter Clinical Study to Evaluate the...Shenzhen Fosun Kairos Bio...
NCT07765810
Outcome of Selective Caries Removal Performed by Undergraduate StudentsJordan University of Science and TechnologyActive Not RecruitingNot Applicable
NCT07765810Active Not Recruiting
Not Applicable
Outcome of Selective Caries Removal Performed by Undergraduate StudentsJordan University of Scie...
NCT07764822
Eye Tracking and Autism in Former Preterm InfantsIndiana UniversityNot Yet RecruitingNot Applicable
NCT07764822Not Yet Recruiting
Not Applicable
Eye Tracking and Autism in Former Preterm InfantsIndiana University
NCT07764796
Mobile Health Patient Navigation for the Improvement of Screening and the Early Detection of Breast Cancer in Women Accessing Primary Care Clinics in KenyaEmory UniversityRecruitingNot Applicable
NCT07764796Recruiting
Not Applicable
Mobile Health Patient Navigation for the Improvement of Screening and the Early...Emory University
NCT07764575
Predictors of Extubation Failure in Ventilated NeonatesAssiut UniversityNot Yet Recruiting
NCT07764575Not Yet Recruiting
—
Predictors of Extubation Failure in Ventilated NeonatesAssiut University
NCT07766109
Discontinuation or Continuation of SGLT-2 Inhibitors Before Cardiac SurgeryUniversity Hospital, ToulouseNot Yet RecruitingPhase 4
NCT07766109Not Yet Recruiting
Phase 4
Discontinuation or Continuation of SGLT-2 Inhibitors Before Cardiac SurgeryUniversity Hospital, Toul...
NCT07766681
Epidural Spinal Cord Stimulation for Respiratory Recovery in Brain InjuryCenter for Excellence in Brain Science and Intelligence Technology, Chinese Academy of SciencesNot Yet RecruitingNot Applicable
NCT07766681Not Yet Recruiting
Not Applicable
Epidural Spinal Cord Stimulation for Respiratory Recovery in Brain InjuryCenter for Excellence in...
NCT07766616
Acceptance and Commitment Therapy Plus Physiotherapy for Chronic Low Back PainAl-Azhar UniversityNot Yet RecruitingNot Applicable
NCT07766616Not Yet Recruiting
Not Applicable
Acceptance and Commitment Therapy Plus Physiotherapy for Chronic Low Back PainAl-Azhar University
NCT07765511
A Study of Macupatide (LY3532226) in Participants With Obesity or Overweight Without Type 2 DiabetesEli Lilly and CompanyNot Yet RecruitingPhase 1
NCT07765511Not Yet Recruiting
Phase 1
A Study of Macupatide (LY3532226) in Participants With Obesity or Overweight Wit...Eli Lilly and Company
NCT07765771
Minimal-Incision Technique With Modified Tracking Pin Placement Versus Standard Robotic-Assisted Total Knee ArthroplastyHallym University Kangnam Sacred Heart HospitalNot Yet RecruitingNot Applicable
NCT07765771Not Yet Recruiting
Not Applicable
Minimal-Incision Technique With Modified Tracking Pin Placement Versus Standard...Hallym University Kangnam...
NCT07766005
A Study of SPY072 in Adults With Moderate to Severe Hidradenitis Suppurativa (The SKYLIGHT Trial)Spyre Therapeutics, Inc.Not Yet RecruitingPhase 2
NCT07766005Not Yet Recruiting
Phase 2
A Study of SPY072 in Adults With Moderate to Severe Hidradenitis Suppurativa (Th...Spyre Therapeutics, Inc.
NCT07766122
Analysis of the Performance of PSMA Emission Tomography in Patients With Prostate Cancer Treated With HIFUUniversity Hospital, ToulouseNot Yet RecruitingPhase 4
NCT07766122Not Yet Recruiting
Phase 4
Analysis of the Performance of PSMA Emission Tomography in Patients With Prostat...University Hospital, Toul...
Result Breakdown
Not yet recruiting15 (75%)
Active, not recruiting2 (10%)
Recruiting2 (10%)
Completed1 (5%)
not_applicable10 (50%)
Not Specified3 (15%)
Phase 23 (15%)
Phase 12 (10%)
Phase 42 (10%)